Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000215798 | SCV000273573 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-15 | criteria provided, single submitter | clinical testing | Insufficient or conflicting evidence |
Labcorp Genetics |
RCV000467410 | SCV000542023 | likely benign | Neurofibromatosis, type 1 | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002321843 | SCV002628026 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-11-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002478786 | SCV002774822 | uncertain significance | not provided | 2021-07-23 | criteria provided, single submitter | clinical testing |